L L Pisters

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. pmc The growing teratoma syndrome: Current review of the literature
    Vladislav Gorbatiy
    Department of Urology, University of Texas Health Science Center, Houston, TX, USA
    Indian J Urol 25:186-9. 2009
  2. ncbi request reprint Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy
    L L Pisters
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 17:2514-20. 1999
  3. ncbi request reprint Evidence that transfer of functional p53 protein results in increased apoptosis in prostate cancer
    Louis L Pisters
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 10:2587-93. 2004
  4. doi request reprint Cryotherapy for prostate cancer: ready for prime time?
    Louis L Pisters
    Department of Urology, University of Texas, M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Curr Opin Urol 20:218-22. 2010
  5. doi request reprint Salvage prostate cryoablation: initial results from the cryo on-line data registry
    Louis L Pisters
    Department of Urology, M D Anderson Cancer Center, Houston, Texas, USA
    J Urol 180:559-63; discussion 563-4. 2008
  6. doi request reprint Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy
    Louis L Pisters
    Department of Urology, The University of Texas, M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Urol 182:517-25; discussion 525-7. 2009
  7. ncbi request reprint Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy
    J I Izawa
    Department of Urology, University of Texas M. D. Anderson Center, Houston, Texas, USA
    J Urol 165:867-70. 2001
  8. ncbi request reprint Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results
    C A Pettaway
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    J Clin Oncol 18:1050-7. 2000
  9. ncbi request reprint Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer
    N Taylor
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 56:755-63. 2003
  10. ncbi request reprint Adult prostate sarcoma: the M. D. Anderson Cancer Center Experience
    W J Sexton
    Department of Urology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
    J Urol 166:521-5. 2001

Detail Information

Publications72

  1. pmc The growing teratoma syndrome: Current review of the literature
    Vladislav Gorbatiy
    Department of Urology, University of Texas Health Science Center, Houston, TX, USA
    Indian J Urol 25:186-9. 2009
    ..This article reviews the current pertinent scientific literature on the diagnosis and management of GTS...
  2. ncbi request reprint Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy
    L L Pisters
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 17:2514-20. 1999
    ..Our objective was to identify clinical pretreatment factors associated with early treatment failure after salvage cryotherapy...
  3. ncbi request reprint Evidence that transfer of functional p53 protein results in increased apoptosis in prostate cancer
    Louis L Pisters
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 10:2587-93. 2004
    ..This study was undertaken to determine the safety of INGN 201 in patients with locally advanced prostate cancer, to assess transgene expression, and to evaluate antitumoral activity...
  4. doi request reprint Cryotherapy for prostate cancer: ready for prime time?
    Louis L Pisters
    Department of Urology, University of Texas, M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Curr Opin Urol 20:218-22. 2010
    ..There has also been a shift toward less invasive approaches to prostate cancer, including cryotherapy. Cryotherapy has undergone considerable change. It is important for clinicians to be aware of the evidence to support its use...
  5. doi request reprint Salvage prostate cryoablation: initial results from the cryo on-line data registry
    Louis L Pisters
    Department of Urology, M D Anderson Cancer Center, Houston, Texas, USA
    J Urol 180:559-63; discussion 563-4. 2008
    ..We report contemporary outcomes of salvage cryoablation at a large number of centers which have participated in the COLD (Cryo On-Line Data) Registry...
  6. doi request reprint Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy
    Louis L Pisters
    Department of Urology, The University of Texas, M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Urol 182:517-25; discussion 525-7. 2009
    ..We compared the treatment outcomes of salvage radical prostatectomy and salvage cryotherapy for patients with locally recurrent prostate cancer after initial radiation therapy...
  7. ncbi request reprint Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy
    J I Izawa
    Department of Urology, University of Texas M. D. Anderson Center, Houston, Texas, USA
    J Urol 165:867-70. 2001
    ..To optimize the potential for local control the technique of salvage cryotherapy should include 2 freeze-thaw cycles and a minimum of 5 cryoprobes. Detectable PSA after salvage cryotherapy is a strong predictor of local failure...
  8. ncbi request reprint Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results
    C A Pettaway
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    J Clin Oncol 18:1050-7. 2000
    ..The neoadjuvant approach was adopted because it allows an in situ assessment of antitumoral activity...
  9. ncbi request reprint Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer
    N Taylor
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 56:755-63. 2003
    ..The optimal role of radiotherapy (RT) to the prostate bed after radical prostatectomy (RP) is the subject of much debate. In this study, the results of adjuvant RT (ART) and salvage RT (SRT) were compared...
  10. ncbi request reprint Adult prostate sarcoma: the M. D. Anderson Cancer Center Experience
    W J Sexton
    Department of Urology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
    J Urol 166:521-5. 2001
    ..CONCLUSIONS: The long-term disease specific survival rate for adults with prostate sarcoma is poor. Early diagnosis and complete surgical resection offer patients the best chance for cure...
  11. ncbi request reprint Radical cystectomy for invasive bladder cancer in the octogenarian
    R S Lance
    Department of Urology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA
    Oncol Rep 8:723-6. 2001
    ..The median survival was 3.5 years. Our results demonstrate that radical cystectomy and ileal conduit urinary diversion should not be withheld from patients on the basis of age...
  12. ncbi request reprint Differential expression of c-erb B2/neu, epidermal growth factor receptor, cytokeratin 8, and the prostatic steroid-binding protein gene in rat ventral prostate during postnatal development
    L L Pisters
    Department of Urology, The University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA
    Prostate 47:164-71. 2001
    ..Both neu and EGFR may be involved in androgen-independent growth of basal cell population in prostate. Prostate 47:164-171, 2001...
  13. ncbi request reprint Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study
    Anita L Sabichi
    University of Texas M D Anderson Cancer Center, Baylor College of Medicine, Houston, Texas, USA
    Clin Cancer Res 12:2178-84. 2006
    ..Epidemiologic and clinical data suggest that selenium could prevent prostate cancer, but it has not been shown that supplemental selenium leads to an increased concentration of selenium in prostate tissue compared with adjacent tissue...
  14. ncbi request reprint Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome?
    Philippe E Spiess
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    BJU Int 99:321-5. 2007
    ..To review our experience with the surgical management of lymph node-positive prostate cancer and to determine if there is a benefit to treating such patients with immediate rather than delayed hormonal therapy (HT)...
  15. ncbi request reprint Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level
    Dan Leibovici
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 109:198-204. 2007
    ..Occasionally, PC progression can occur despite low or undetectable PSA levels. The authors report on the clinical and pathologic characteristics of patients who experienced PC progression with undetectable or low PSA levels...
  16. ncbi request reprint Neoadjuvant therapy before radical prostatectomy: where have we been? Where are we going?
    John Pendleton
    Division of Urology, University of Florida, Jacksonville, FL 32209, USA
    Urol Oncol 25:11-8. 2007
    ..Therefore, this patient population continues to pose a therapeutic dilemma for physicians...
  17. ncbi request reprint Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?
    Gordon A Brown
    Department of Urology, The University of Texas MD Anderson Cancer Center Houston, TX 77030, USA
    BJU Int 98:1176-80. 2006
    ..To evaluate factors associated with disease recurrence and survival in patients undergoing nephroureterectomy for upper urinary tract transitional cell carcinoma (UUT-TCC) in one centre over an 18-year period...
  18. ncbi request reprint Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer
    Philippe E Spiess
    Department of Urologic Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 107:1483-90. 2006
    ..The aim of the present study was to evaluate the authors' PC-RPLND experience and identify predictors of outcome in these patients...
  19. ncbi request reprint Histological changes in prostate biopsies after salvage cryotherapy: effect of chronology and the method of biopsy
    Jonathan I Izawa
    Department of Urology, The University of Texas, M D Anderson Center, Houston, TX 77030, USA
    BJU Int 98:554-8. 2006
    ....
  20. ncbi request reprint Suburethral sling at the time of radical prostatectomy in patients at high risk of postoperative incontinence
    O Lenaine Westney
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    BJU Int 98:308-13. 2006
    ..To evaluate the insertion of a urethral sling at the time of radical prostatectomy (RP) in men at high risk of urinary incontinence after RP...
  21. ncbi request reprint Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer
    Sara S Strom
    Department of Epidemiology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 107:631-9. 2006
    ..The current study sought to determine whether obesity was an independent predictor of biochemical failure (BF) and clinical recurrence (CF) among patients treated with external-beam radiotherapy (EBRT)...
  22. ncbi request reprint Impact of fellowship training on pathologic outcomes and complication rates of radical prostatectomy
    Charles J Rosser
    Division of Urology, University of Florida, Jacksonville, Florida 32209, USA
    Cancer 107:54-9. 2006
    ..The study was conducted to assess the results of radical prostatectomy (RP) performed by fellowship-trained surgeons in the first year of independent practice...
  23. ncbi request reprint Surgery for locally advanced disease
    Philippe E Spiess
    Department of Urology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1373, Houston, TX 77030, USA
    Curr Urol Rep 7:209-16. 2006
    ....
  24. ncbi request reprint Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy
    Philippe E Spiess
    Department of Urology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 107:275-80. 2006
    ..The purpose of the current study was to evaluate serum PSA level and PSA DT as predictors of salvage cryotherapy outcomes in patients being treated for postradiotherapy locally recurrent PCa...
  25. ncbi request reprint An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer
    Steven J Frank
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    J Urol 177:2151-6; discussion 2156. 2007
    ..Monotherapy with radical prostatectomy, high dose external beam radiotherapy or a (125)I implant is reported to produce equivalent outcomes. We assessed the health related quality of life associated with these 3 treatment approaches...
  26. ncbi request reprint Initial modulation of the tumor microenvironment accounts for thalidomide activity in prostate cancer
    Eleni Efstathiou
    Department of Genitourinary Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 13:1224-31. 2007
    ..We did a preoperative study to test the hypothesis that thalidomide, an active agent in metastatic disease, is a modulator of the tumor microenvironment...
  27. doi request reprint Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry
    J Stephen Jones
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA
    J Urol 180:554-8. 2008
    ..We report the largest data set to date to our knowledge regarding outcomes for primary whole gland prostate cryoablation...
  28. doi request reprint Quality of life and satisfaction with outcome among prostate-cancer survivors
    Martin G Sanda
    Departments of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Harvard University, Boston, MA 02215, USA
    N Engl J Med 358:1250-61. 2008
    ....
  29. doi request reprint Salvage surgery for locally recurrent prostate cancer after radiation therapy: tricks of the trade
    Dan Leibovici
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Urol Oncol 26:9-16. 2008
    ..In addition, we discuss the importance and surgical details of using a well-vascularized rectus flap as a method of reducing perioperative morbidity...
  30. doi request reprint Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer
    Anita L Sabichi
    Department of Clinical Cancer Prevention, The University of Texas M D Anderson Cancer Center, Houston, TX 77230 1439, USA
    Clin Cancer Res 14:224-9. 2008
    ..The study aims to evaluate the efficacy and toxicity of fenretinide in preventing tumor recurrence in patients with transitional cell carcinoma (TCC) of the bladder...
  31. ncbi request reprint Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection
    Philippe E Spiess
    Department of Urologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Urology 70:1173-8. 2007
    ....
  32. ncbi request reprint Treatment failure after primary and salvage therapy for prostate cancer
    Louis L Pisters
    Cancer 112:225-7. 2008
  33. ncbi request reprint An in vivo orthotopic canine model to evaluate distribution of intraprostatic injectate: implications for gene therapy and drug delivery for prostate cancer
    Wassim Kassouf
    Department of Urology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Urology 70:822-5. 2007
    ..We sought to evaluate the optimal injection scheme and feasibility of magnetic resonance imaging (MRI) using a surrogate solution to assess the distribution of injectate in an orthotopic canine model...
  34. ncbi request reprint Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression?
    Philippe E Spiess
    Department of Urologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 110:2700-8. 2007
    ..The objective of the current study was to determine the clinical variables that predict this adverse outcome...
  35. ncbi request reprint Organ preservation for muscle-invasive bladder cancer by transurethral resection
    Dan Leibovici
    Department of Urology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Urology 70:473-6. 2007
    ..To determine the feasibility of bladder preservation using transurethral resection for patients with muscle-invasive cancer and to determine the proportion of patients with muscle-invasive disease who would be eligible for this approach...
  36. ncbi request reprint A randomized prospective trial evaluating testosterone, haemoglobin kinetics and quality of life, during and after 12 months of androgen deprivation after prostatectomy: results from the Postoperative Adjuvant Androgen Deprivation trial
    Peter C Black
    Deparment of Urology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    BJU Int 100:63-9. 2007
    ..To assess testosterone and haemoglobin kinetics in the Postoperative Adjuvant Androgen Deprivation (PAAD) trial, and correlate these with quality of life (QoL) in this prospective randomized study...
  37. ncbi request reprint Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients
    Ashish M Kamat
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 110:62-7. 2007
    ..Micropapillary bladder carcinoma is a rare variant of urothelial carcinoma. To improve understanding of this disease, the authors performed a retrospective review of their experience...
  38. ncbi request reprint Salvage prostatectomy with bladder neck closure, continent catheterizable stoma and bladder augmentation: feasibility and patient reported continence outcomes at 32 months
    Elise De
    Division of Urology, Albany Medical Center, 23 Hackett Boulevard, Albany, NY 12208, USA
    J Urol 177:2200-4; discussion 2204. 2007
    ..Urinary incontinence and patient satisfaction were evaluated...
  39. ncbi request reprint Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with radical prostatectomy
    Charles J Rosser
    Department of Urology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Urology 67:769-73. 2006
    ..To determine the biochemical disease-free survival rates in patients 60 years old or younger who were treated with surgery for localized prostate cancer...
  40. ncbi request reprint The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma
    Ashish M Kamat
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, Texas, 77030, USA
    J Urol 175:881-5. 2006
    ..Micropapillary bladder carcinoma is a rare variant of UC. Due to paucity of data regarding treatment outcomes, patients with nonmuscle invasive micropapillary UC often receive intravesical therapy in an attempt at bladder preservation...
  41. ncbi request reprint Clinical features and treatment outcome of Hispanic men with prostate cancer following external beam radiotherapy
    Charles J Rosser
    Department of Urology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    J Urol 170:1856-9. 2003
    ..We retrospectively analyzed the clinical characteristics and outcomes of Hispanic men compared with other groups who underwent radiotherapy alone for localized or locally advanced prostate cancer...
  42. ncbi request reprint Cryotherapy for prostate cancer
    Carlos E Bermejo
    Department of Urology, The University of Texas MD Anderson Cancer Center, Houston 77030, USA
    Expert Rev Anticancer Ther 3:393-401. 2003
    ..The role of cryotherapy in localized prostate cancer is reviewed...
  43. ncbi request reprint Incomplete glandular ablation after salvage cryotherapy for recurrent prostate cancer after radiotherapy
    Jonathan I Izawa
    Department of Urology, The University of Texas M D Anderson Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 56:468-72. 2003
    ..To determine the clinical variables associated with inadequate salvage cryotherapy and to correlate the disease-free survival rates associated with biopsy results in prostate cancer (CaP)...
  44. ncbi request reprint Salvage radical prostatectomy: refinement of an effective procedure
    Louis L Pisters
    Department of Urology, The University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    Semin Radiat Oncol 13:166-74. 2003
    ..The biochemical outcome after salvage prostatectomy appears superior to the biochemical outcome after salvage cryotherapy or brachytherapy. Salvage radical prostatectomy may cure approximately 50% of well-selected patients...
  45. ncbi request reprint Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma
    Charles J Rosser
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 56:1-6. 2003
    ....
  46. ncbi request reprint Repeat retroperitoneal lymph node dissection for metastatic testis cancer
    Wade J Sexton
    Department of Urology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Urol 169:1353-6. 2003
    ..We report pathological results, perioperative complications and patient outcome in 21 men after repeat retroperitoneal lymph node dissection for metastatic testis cancer...
  47. ncbi request reprint Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience
    Arlene O Siefker-Radtke
    Center for Genitourinary Oncology, Department of Genitourinary Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, USA
    J Urol 169:1295-8. 2003
    ..To improve our understanding of urachal carcinoma and define outcome with current management, we performed a retrospective review of cases seen at the M. D. Anderson Cancer Center...
  48. ncbi request reprint Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer
    Charles J Rosser
    Department of Urology, The University of Texas, M D Anderson Cancer Center, Houston 77030, USA
    J Urol 168:2001-5. 2002
    ..We characterize the prostate-specific antigen (PSA) bounce in patients who underwent external beam radiation therapy for prostate cancer and correlate the PSA bounce with the development of biochemical disease progression...
  49. ncbi request reprint Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation
    Charles J Rosser
    Department of Urology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Urol 168:536-41. 2002
    ..We also evaluated prognostic factors in the 2 age groups...
  50. ncbi request reprint Biological significance of c-met over expression in papillary renal cell carcinoma
    Paul Sweeney
    Department of Urology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Urol 168:51-5. 2002
    ..We assessed c-met expression in papillary renal cell carcinomas and evaluated the prognostic significance of c-met expression in patients with this tumor...
  51. ncbi request reprint Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome
    Jonathan I Izawa
    Department of Urology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 20:2664-71. 2002
    ....
  52. ncbi request reprint The association of p21((WAF-1/CIP1)) with progression to androgen-independent prostate cancer
    Karim Fizazi
    Department of Genitourinary Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 8:775-81. 2002
    ..Another explanation involves the regulation of p21 expression by the androgen receptor, which also suggests that p21 may have antiapoptotic function in prostate cancer...
  53. ncbi request reprint Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer
    Ashish M Kamat
    Department of Urology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    J Urol 170:1868-71. 2003
    ..We describe a group of patients who had intractable perineal pain due to locally recurrent prostate cancer and underwent total pelvic exenteration for palliation...
  54. ncbi request reprint Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience
    Arlene O Siefker-Radtke
    Center for Genitourinary Oncology and Department of Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, 77030 4009, USA
    J Urol 171:145-8. 2004
    ..The role of surgery for metastatic disease is not well established for urothelial cancer, but is sometimes undertaken in the face of persistent or recurrent disease that can be surgically resected...
  55. ncbi request reprint Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma
    Badar M Mian
    Departments of Urology, Surgical Oncology and GU Medical Oncology, University of Texas, M D Anderson Cancer Center, Houston, TX, USA
    J Urol 167:65-70. 2002
    ..Sarcomatoid renal cell carcinoma often has an aggressive clinical course characterized by rapid disease progression. We evaluate prognostic factors for patient survival and the effect of treatment on patient outcome...
  56. ncbi request reprint Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancer
    Dan Leibovici
    Departments of Urology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    J Urol 174:2186-90. 2005
    ..We evaluated the palliative effect of cystoprostatectomy (CP) for palliating pelvic symptoms in patients with bladder invasion by prostate cancer...
  57. ncbi request reprint Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer
    Jeri Kim
    Department of Genitourinary Medical Oncology, University of Massachusetts Medical School, Lazare Research Building, Room 504, 364 Plantation Street, Worcester, MA 01605 2324, USA
    Cancer Epidemiol Biomarkers Prev 14:1697-702. 2005
    ..To determine the effects of selenium and vitamin E in blood and prostate tissue, we undertook a preoperative feasibility study complementary to the currently ongoing Selenium and Vitamin E Cancer Prevention Trial...
  58. ncbi request reprint Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes
    Kamran Ahrar
    The Department of Diagnostic Radiology, The University of Texas M D Anderson Cancer Center, 77030 4009, USA
    J Vasc Interv Radiol 16:679-88. 2005
    ..To report the safety, technical success, and effectiveness of percutaneous radiofrequency (RF) ablation for renal tumors...
  59. ncbi request reprint Symptomatic local recurrence of prostate carcinoma after radiation therapy
    Dan Leibovici
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 103:2060-6. 2005
    ..Most reports on the results of RT for localized prostate carcinoma (PC) do not address this endpoint. The objective of this study was to determine the incidence of SLRPC and to identify the risk factors for this endpoint...
  60. ncbi request reprint Salvage surgery for bulky local recurrence of prostate cancer following radical prostatectomy
    Dan Leibovici
    Department of Urology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Urol 173:781-3. 2005
    ..We report our experience with salvage radical surgery as palliative treatment in patients with bulky recurrence of prostate cancer following radical prostatectomy (RP)...
  61. ncbi request reprint Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancer
    Dan Leibovici
    Department of Urology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Prostate 62:101-4. 2005
    ....
  62. pmc Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer
    Charles J Rosser
    Department of Urology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    J Natl Med Assoc 96:939-44. 2004
    ..We retrospectively analyzed the clinical characteristics and outcomes of various racial and ethnic groups who underwent radiotherapy alone for localized or locally advanced prostate cancer...
  63. ncbi request reprint Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience
    Arlene O Siefker-Radtke
    Center for Genitourinary Oncology, and Department of Genitourinary Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, 77030 4009, USA
    J Urol 172:481-4. 2004
    ..Neuroendocrine tumors of the bladder comprise a small subset of all bladder tumors. To improve our understanding of this tumor and define outcomes with current management, we performed a retrospective review of these cases...
  64. ncbi request reprint Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors
    Ashish M Kamat
    Department of Urology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Urology 63:46-50. 2004
    ....
  65. ncbi request reprint Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation
    Charles J Rosser
    Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer Gene Ther 11:273-9. 2004
    ..These findings suggest that overexpression of Bcl-2 result in radioresistance and inability of radiation to cause its typical G2M cell-cycle arrest...
  66. ncbi request reprint Rise in serum PSA of 1.5 ng/mL above 24-month nadir after external beam radiotherapy is predictive of biochemical failure
    Ashish M Kamat
    Department of Urology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Urology 63:1132-7. 2004
    ..To determine whether a rise in the serum prostate-specific antigen (PSA) concentration 24 months or later after completion of external beam radiotherapy (EBRT) for prostate cancer could predict for biochemical failure...
  67. ncbi request reprint Early nasogastric tube removal combined with metoclopramide after postchemotherapy retroperitoneal lymph node dissection for metastatic testicular nonseminomatous germ cell tumor
    John W Davis
    Department of Urology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Urology 59:579-83. 2002
    ..To evaluate the efficacy of combining early nasogastric tube (NGT) removal and metoclopramide after postchemotherapy retroperitoneal lymph node dissection (RPLND) in decreasing complications, time to diet tolerance, and discharge...
  68. ncbi request reprint Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?
    Paul Sweeney
    Department of Urology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Urol 169:2113-7. 2003
    ....
  69. doi request reprint Can digital rectal examination or transrectal ultrasonography biopsy findings predict the side of nodal metastasis in prostate cancer?
    Philippe E Spiess
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Urol Oncol 26:25-30. 2008
    ..To assess the use of several preoperative parameters in predicting the side of pelvic lymph node metastasis in patients with prostate cancer...
  70. ncbi request reprint Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features
    Shi Ming Tu
    Department of Genitourinary Medical Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Cancer 94:2610-7. 2002
    ..Despite the proximity, prostate carcinoma seldom metastasizes to the penis or testis...
  71. ncbi request reprint Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience
    James G Evans
    Department of Urologic Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Urol 176:1463-7. 2006
    ..We determined the clinical presentation, risk factors and optimal treatment of chylous ascites that develop after retroperitoneal lymph node dissection in patients with testicular cancer...
  72. ncbi request reprint Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi
    Paul Sweeney
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Urol Oncol 21:327-33. 2003
    ..Selected patients with metastatic renal cancer may benefit from aggressive surgical resection of the primary tumor and associated tumor thrombus...